Literature DB >> 26896818

Fibroblast growth factor 23 signaling in hippocampal cells: impact on neuronal morphology and synaptic density.

Niko Hensel1, Anne Schön2, Timo Konen1, Verena Lübben1,3, Benjamin Förthmann1, Olga Baron1, Claudia Grothe1,3, Maren Leifheit-Nestler2, Peter Claus1,3, Dieter Haffner2.   

Abstract

Endocrine fibroblast growth factor 23 (FGF23) is predominantly secreted by osteocytes and facilitates renal phosphate excretion. However, FGF23 is also present in cerebrospinal fluid. In chronic kidney disease, FGF23 serum levels are excessively elevated and associated with learning and memory deficits. Structural plasticity of the hippocampus such as formation of new synapses or an altered dendritic arborization comprises a cellular and morphological correlate of memory formation. Therefore, we hypothesize that FGF23 alters hippocampal neuron morphology and synapses. To address this, we prepared primary murine hippocampal cultures and incubated them with recombinant FGF23 alone or together with a soluble isoform of its co-receptor α-Klotho. Neuronal expression of a fluorescent reporter allowed for a detailed evaluation of the neuronal morphology by Sholl analysis. Additionally, we evaluated synaptic density, identified by stainings, for synaptic markers. We show an enhanced number of primary neurites combined with a reduced arborization, resulting in a less complex morphology of neurons treated with FGF23. Moreover, FGF23 enhances the synaptic density in a FGF-receptor (FGF-R) dependent manner. Finally, we addressed the corresponding signaling events downstream of FGF-R employing a combination of western blots and quantitative immunofluorescence. Interestingly, FGF23 induces phospholipase Cγ activity in primary hippocampal neurons. Co-application of soluble α-Klotho leads to activation of the Akt-pathway and modifies FGF23-impact on neuronal morphology and synaptic density. Compared with other FGFs, this alternative signaling pattern is a possible reason for differential effects of FGF23 on hippocampal neurons and may thereby contribute to learning and memory deficits in chronic kidney disease patients. In this study, we show that fibroblast growth factor 23 inhibits neuronal ramification and enhances the synaptic density in primary hippocampal cultures accompanied by phospholipase Cγ-activation. Co-application of the co-receptor α-Klotho leads to an Akt-activation and further modifies neuronal morphology and number of synapses. Those effects provide a mechanistic basis for memory deficits in patients suffering from chronic kidney disease (CKD) characterized by excessively elevated FGF23 levels as well as memory deficits.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  Hippocampus; Sholl analysis; chronic kidney disease; cognitive impairment; neurotrophic; phospholipase Cγ

Mesh:

Substances:

Year:  2016        PMID: 26896818     DOI: 10.1111/jnc.13585

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

Review 1.  Extrarenal effects of FGF23.

Authors:  Dieter Haffner; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2016-10-04       Impact factor: 3.714

2.  Fibroblast Growth Factor 9 Stimulates Neuronal Length Through NF-kB Signaling in Striatal Cell Huntington's Disease Models.

Authors:  Issa Olakunle Yusuf; Hsiu-Mei Chen; Pei-Hsun Cheng; Chih-Yi Chang; Shaw-Jenq Tsai; Jih-Ing Chuang; Chia-Ching Wu; Bu-Miin Huang; H Sunny Sun; Chuan-Mu Chen; Shang-Hsun Yang
Journal:  Mol Neurobiol       Date:  2021-01-09       Impact factor: 5.590

Review 3.  αKlotho-FGF23 interactions and their role in kidney disease: a molecular insight.

Authors:  Edward R Smith; Stephen G Holt; Tim D Hewitson
Journal:  Cell Mol Life Sci       Date:  2019-07-26       Impact factor: 9.261

Review 4.  Hyperphosphatemia and Chronic Kidney Disease: A Major Daily Concern Both in Adults and in Children.

Authors:  Justine Bacchetta; Julie Bernardor; Charlotte Garnier; Corentin Naud; Bruno Ranchin
Journal:  Calcif Tissue Int       Date:  2020-01-29       Impact factor: 4.333

5.  27-Hydroxycholesterol Alters Synaptic Structural and Functional Plasticity in Hippocampal Neuronal Cultures.

Authors:  Yushan Wang; Yu An; Dandi Zhang; Huiyan Yu; Xiaona Zhang; Ying Wang; Lingwei Tao; Rong Xiao
Journal:  J Neuropathol Exp Neurol       Date:  2019-03-01       Impact factor: 3.685

6.  X-linked hypophosphatemia, obesity and arterial hypertension: data from the XLH21 study.

Authors:  Louisa Bloudeau; Agnès Linglart; Sacha Flammier; Aurélie Portefaix; Aurélia Bertholet-Thomas; Sanaa Eddiry; Anna Barosi; Jean-Pierre Salles; Valérie Porquet-Bordes; Anya Rothenbuhler; Christelle Roger; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2022-06-27       Impact factor: 3.714

7.  Phosphate Dysregulation and Neurocognitive Sequelae.

Authors:  John Acquaviva; Hosam G Abdelhady; Mohammed S Razzaque
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 8.  Circulating α-klotho regulates metabolism via distinct central and peripheral mechanisms.

Authors:  Taylor Landry; Daniel Shookster; Hu Huang
Journal:  Metabolism       Date:  2021-06-19       Impact factor: 13.934

Review 9.  Physiological Actions of Fibroblast Growth Factor-23.

Authors:  Reinhold G Erben
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-28       Impact factor: 5.555

Review 10.  FGF23 Actions on Target Tissues-With and Without Klotho.

Authors:  Beatrice Richter; Christian Faul
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-02       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.